Deutsche Bank Analysts Give Gerresheimer (GXI) a €66.00 Price Target
A number of other brokerages have also recently commented on GXI. Commerzbank set a €77.00 ($91.67) target price on shares of Gerresheimer and gave the company a buy rating in a report on Monday, October 23rd. Hauck & Aufhaeuser set a €55.00 ($65.48) target price on shares of Gerresheimer and gave the company a sell rating in a report on Wednesday, January 10th. set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, September 28th. Berenberg Bank set a €75.00 ($89.29) target price on shares of Gerresheimer and gave the company a buy rating in a report on Friday, December 8th. Finally, JPMorgan Chase & Co. set a €87.70 ($104.40) target price on shares of Gerresheimer and gave the company a buy rating in a report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of Hold and an average target price of €71.20 ($84.76).
Shares of Gerresheimer (ETR:GXI) traded up €0.85 ($1.01) during trading hours on Monday, hitting €73.25 ($87.20). 97,607 shares of the stock were exchanged, compared to its average volume of 110,702. Gerresheimer has a 1-year low of €59.97 ($71.39) and a 1-year high of €78.25 ($93.15). The stock has a market capitalization of $2,300.00 and a PE ratio of 51.95.
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.